Patients in the highest-exposure group, ie, those with more than 385 defined daily doses of PPIs, have an 83% higher risk for gastric neuroendocrine tumors than nonusers.

If you feel like you’ve hit a treatment wall with proton pump inhibitors (PPIs), here's why your EoE symptoms may still be flaring and what you can do about it.